The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Therapeutic Plasma Exchange Market Research Report 2024
Synopsis
Plasma exchange is a procedure that separates and removes plasma from the blood in order to eliminate a disease substance circulating in the plasma. The red blood cells, white blood cells, and platelets are returned to the patient, along with a prescribed replacement fluid. Plasma exchange is widely performed in the treatment of various chronic diseases as first line or as second line of therapy or as a supportive treatment.
The global Therapeutic Plasma Exchange market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Therapeutic plasma exchange (TPE) has wide applications in the treatment of neurological, renal, hematological, and metabolic disorders. The indications for using therapeutic plasma exchange procedures as a line of treatment are regulated through guidelines provided by the American Society for Apheresis (ASFA). It categorizes the indications in four parts: category I to IV. Category I and II depict TPE as first or second line of treatment for many neurological, renal, and hematological disorders such as chronic inflammatory demyelinating polyneuropathy (CIDP), myasthenia gravis, Guillain-Barre syndrome, and thrombotic thrombocytopenic purpura (TTP).
This report aims to provide a comprehensive presentation of the global market for Therapeutic Plasma Exchange, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Therapeutic Plasma Exchange.
Report Scope
The Therapeutic Plasma Exchange market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Therapeutic Plasma Exchange market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Therapeutic Plasma Exchange companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Asahi Kasei
Baxter International
Terumo
B. Braun
Fresenius Kabi
Kawasumi Laboratories
Haemonetics
Cerus
Hemacare
Medica
Segment by Type
Neurological Disorders
Renal Disorders
Hematology Disorders
Metabolic Disorders
Others
Segment by Application
Hospitals
Specialty Clinics
Ambulatory Surgical Centers
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Therapeutic Plasma Exchange companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Plasma exchange is a procedure that separates and removes plasma from the blood in order to eliminate a disease substance circulating in the plasma. The red blood cells, white blood cells, and platelets are returned to the patient, along with a prescribed replacement fluid. Plasma exchange is widely performed in the treatment of various chronic diseases as first line or as second line of therapy or as a supportive treatment.
The global Therapeutic Plasma Exchange market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Therapeutic plasma exchange (TPE) has wide applications in the treatment of neurological, renal, hematological, and metabolic disorders. The indications for using therapeutic plasma exchange procedures as a line of treatment are regulated through guidelines provided by the American Society for Apheresis (ASFA). It categorizes the indications in four parts: category I to IV. Category I and II depict TPE as first or second line of treatment for many neurological, renal, and hematological disorders such as chronic inflammatory demyelinating polyneuropathy (CIDP), myasthenia gravis, Guillain-Barre syndrome, and thrombotic thrombocytopenic purpura (TTP).
This report aims to provide a comprehensive presentation of the global market for Therapeutic Plasma Exchange, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Therapeutic Plasma Exchange.
Report Scope
The Therapeutic Plasma Exchange market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Therapeutic Plasma Exchange market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Therapeutic Plasma Exchange companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Asahi Kasei
Baxter International
Terumo
B. Braun
Fresenius Kabi
Kawasumi Laboratories
Haemonetics
Cerus
Hemacare
Medica
Segment by Type
Neurological Disorders
Renal Disorders
Hematology Disorders
Metabolic Disorders
Others
Segment by Application
Hospitals
Specialty Clinics
Ambulatory Surgical Centers
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Therapeutic Plasma Exchange companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Therapeutic Plasma Exchange Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Neurological Disorders
1.2.3 Renal Disorders
1.2.4 Hematology Disorders
1.2.5 Metabolic Disorders
1.2.6 Others
1.3 Market by Application
1.3.1 Global Therapeutic Plasma Exchange Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Specialty Clinics
1.3.4 Ambulatory Surgical Centers
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Therapeutic Plasma Exchange Market Perspective (2019-2030)
2.2 Therapeutic Plasma Exchange Growth Trends by Region
2.2.1 Global Therapeutic Plasma Exchange Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Therapeutic Plasma Exchange Historic Market Size by Region (2019-2024)
2.2.3 Therapeutic Plasma Exchange Forecasted Market Size by Region (2025-2030)
2.3 Therapeutic Plasma Exchange Market Dynamics
2.3.1 Therapeutic Plasma Exchange Industry Trends
2.3.2 Therapeutic Plasma Exchange Market Drivers
2.3.3 Therapeutic Plasma Exchange Market Challenges
2.3.4 Therapeutic Plasma Exchange Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Therapeutic Plasma Exchange Players by Revenue
3.1.1 Global Top Therapeutic Plasma Exchange Players by Revenue (2019-2024)
3.1.2 Global Therapeutic Plasma Exchange Revenue Market Share by Players (2019-2024)
3.2 Global Therapeutic Plasma Exchange Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Therapeutic Plasma Exchange Revenue
3.4 Global Therapeutic Plasma Exchange Market Concentration Ratio
3.4.1 Global Therapeutic Plasma Exchange Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Therapeutic Plasma Exchange Revenue in 2023
3.5 Therapeutic Plasma Exchange Key Players Head office and Area Served
3.6 Key Players Therapeutic Plasma Exchange Product Solution and Service
3.7 Date of Enter into Therapeutic Plasma Exchange Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Therapeutic Plasma Exchange Breakdown Data by Type
4.1 Global Therapeutic Plasma Exchange Historic Market Size by Type (2019-2024)
4.2 Global Therapeutic Plasma Exchange Forecasted Market Size by Type (2025-2030)
5 Therapeutic Plasma Exchange Breakdown Data by Application
5.1 Global Therapeutic Plasma Exchange Historic Market Size by Application (2019-2024)
5.2 Global Therapeutic Plasma Exchange Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Therapeutic Plasma Exchange Market Size (2019-2030)
6.2 North America Therapeutic Plasma Exchange Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Therapeutic Plasma Exchange Market Size by Country (2019-2024)
6.4 North America Therapeutic Plasma Exchange Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Therapeutic Plasma Exchange Market Size (2019-2030)
7.2 Europe Therapeutic Plasma Exchange Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Therapeutic Plasma Exchange Market Size by Country (2019-2024)
7.4 Europe Therapeutic Plasma Exchange Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Therapeutic Plasma Exchange Market Size (2019-2030)
8.2 Asia-Pacific Therapeutic Plasma Exchange Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Therapeutic Plasma Exchange Market Size by Region (2019-2024)
8.4 Asia-Pacific Therapeutic Plasma Exchange Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Therapeutic Plasma Exchange Market Size (2019-2030)
9.2 Latin America Therapeutic Plasma Exchange Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Therapeutic Plasma Exchange Market Size by Country (2019-2024)
9.4 Latin America Therapeutic Plasma Exchange Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Therapeutic Plasma Exchange Market Size (2019-2030)
10.2 Middle East & Africa Therapeutic Plasma Exchange Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Therapeutic Plasma Exchange Market Size by Country (2019-2024)
10.4 Middle East & Africa Therapeutic Plasma Exchange Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Asahi Kasei
11.1.1 Asahi Kasei Company Detail
11.1.2 Asahi Kasei Business Overview
11.1.3 Asahi Kasei Therapeutic Plasma Exchange Introduction
11.1.4 Asahi Kasei Revenue in Therapeutic Plasma Exchange Business (2019-2024)
11.1.5 Asahi Kasei Recent Development
11.2 Baxter International
11.2.1 Baxter International Company Detail
11.2.2 Baxter International Business Overview
11.2.3 Baxter International Therapeutic Plasma Exchange Introduction
11.2.4 Baxter International Revenue in Therapeutic Plasma Exchange Business (2019-2024)
11.2.5 Baxter International Recent Development
11.3 Terumo
11.3.1 Terumo Company Detail
11.3.2 Terumo Business Overview
11.3.3 Terumo Therapeutic Plasma Exchange Introduction
11.3.4 Terumo Revenue in Therapeutic Plasma Exchange Business (2019-2024)
11.3.5 Terumo Recent Development
11.4 B. Braun
11.4.1 B. Braun Company Detail
11.4.2 B. Braun Business Overview
11.4.3 B. Braun Therapeutic Plasma Exchange Introduction
11.4.4 B. Braun Revenue in Therapeutic Plasma Exchange Business (2019-2024)
11.4.5 B. Braun Recent Development
11.5 Fresenius Kabi
11.5.1 Fresenius Kabi Company Detail
11.5.2 Fresenius Kabi Business Overview
11.5.3 Fresenius Kabi Therapeutic Plasma Exchange Introduction
11.5.4 Fresenius Kabi Revenue in Therapeutic Plasma Exchange Business (2019-2024)
11.5.5 Fresenius Kabi Recent Development
11.6 Kawasumi Laboratories
11.6.1 Kawasumi Laboratories Company Detail
11.6.2 Kawasumi Laboratories Business Overview
11.6.3 Kawasumi Laboratories Therapeutic Plasma Exchange Introduction
11.6.4 Kawasumi Laboratories Revenue in Therapeutic Plasma Exchange Business (2019-2024)
11.6.5 Kawasumi Laboratories Recent Development
11.7 Haemonetics
11.7.1 Haemonetics Company Detail
11.7.2 Haemonetics Business Overview
11.7.3 Haemonetics Therapeutic Plasma Exchange Introduction
11.7.4 Haemonetics Revenue in Therapeutic Plasma Exchange Business (2019-2024)
11.7.5 Haemonetics Recent Development
11.8 Cerus
11.8.1 Cerus Company Detail
11.8.2 Cerus Business Overview
11.8.3 Cerus Therapeutic Plasma Exchange Introduction
11.8.4 Cerus Revenue in Therapeutic Plasma Exchange Business (2019-2024)
11.8.5 Cerus Recent Development
11.9 Hemacare
11.9.1 Hemacare Company Detail
11.9.2 Hemacare Business Overview
11.9.3 Hemacare Therapeutic Plasma Exchange Introduction
11.9.4 Hemacare Revenue in Therapeutic Plasma Exchange Business (2019-2024)
11.9.5 Hemacare Recent Development
11.10 Medica
11.10.1 Medica Company Detail
11.10.2 Medica Business Overview
11.10.3 Medica Therapeutic Plasma Exchange Introduction
11.10.4 Medica Revenue in Therapeutic Plasma Exchange Business (2019-2024)
11.10.5 Medica Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
